Antisense Therapeutics Liabilities 2024

Antisense Therapeutics Aktienanalyse

What does Antisense Therapeutics do?

Antisense Therapeutics Ltd is an Australian biopharmaceutical company that focuses on developing novel therapies for rare and severe diseases. The company was founded in 1987 and is headquartered in Melbourne. Antisense Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Antisense Therapeutics's Liabilities

Antisense Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Antisense Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Antisense Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Antisense Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Antisense Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Antisense Therapeutics Stock

What is the level of liabilities of Antisense Therapeutics this year?

Antisense Therapeutics has a debt balance of 2.87 M AUD this year.

What were the liabilities of Antisense Therapeutics compared to the previous year?

The liabilities of Antisense Therapeutics have increased by 121.38% increased compared to the previous year.

What are the consequences of high debt for investors of Antisense Therapeutics?

High liabilities can pose a risk for investors of Antisense Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Antisense Therapeutics?

Low liabilities mean that Antisense Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Antisense Therapeutics affect the company?

An increase in liabilities of Antisense Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Antisense Therapeutics affect the company?

A decrease in the liabilities of Antisense Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Antisense Therapeutics?

Some factors that can influence the liabilities of Antisense Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Antisense Therapeutics so important for investors?

The liabilities of Antisense Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Antisense Therapeutics take to modify the liabilities?

To change its liabilities, Antisense Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Antisense Therapeutics pay?

Over the past 12 months, Antisense Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Antisense Therapeutics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Antisense Therapeutics?

The current dividend yield of Antisense Therapeutics is .

When does Antisense Therapeutics pay dividends?

Antisense Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Antisense Therapeutics?

Antisense Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Antisense Therapeutics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Antisense Therapeutics located?

Antisense Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Antisense Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Antisense Therapeutics from 6/25/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 6/25/2024.

When did Antisense Therapeutics pay the last dividend?

The last dividend was paid out on 6/25/2024.

What was the dividend of Antisense Therapeutics in the year 2023?

In the year 2023, Antisense Therapeutics distributed 0 AUD as dividends.

In which currency does Antisense Therapeutics pay out the dividend?

The dividends of Antisense Therapeutics are distributed in AUD.